Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period

H Randall Griffith1, Kelli L Netson, Lindy E Harrell

  • 1Department of Neurology, University of Alabama at Birmingham, 1216 Jefferson Tower, 625 19th Street South, Birmingham, AL, USA. rlgriffith@uabmc.edu

Insights

Neuropsychological tests can predict Alzheimer's disease (AD) progression in individuals with mild cognitive impairment (MCI). Specific scores on the Dementia Rating Scale and Wechsler Memory Scale accurately identify those at high risk for conversion to AD.

Area of Science:

  • Neurology
  • Neuropsychology
  • Gerontology

Background:

  • Amnestic mild cognitive impairment (MCI) is a known precursor to Alzheimer's disease (AD).
  • Accurately identifying MCI patients who will progress to AD is challenging but crucial for timely intervention.
  • Early detection of MCI conversion to AD aids in treatment planning and clinical trial recruitment.

Purpose of the Study:

  • To predict the conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD) within a two-year timeframe.
  • To evaluate the efficacy of baseline demographic and neuropsychological data in predicting MCI to AD conversion.
  • To establish specific neuropsychological test cutoff scores for identifying individuals at high risk for AD progression.

Main Methods:

  • A cohort of 49 MCI patients was analyzed using baseline demographic and neuropsychological data.
  • Stepwise discriminant function analysis was employed, focusing on Dementia Rating Scale (DRS) Initiation/Perseveration and Wechsler Memory Scale, third edition (WMS-III) Visual Reproduction Percent Retention scores.
  • Classification rates, sensitivity, and specificity were calculated to assess predictive accuracy.

Main Results:

  • The analysis correctly classified 85.7% of MCI patients as converters or non-converters to AD.
  • High sensitivity (76.9%) and specificity (88.9%) were achieved using DRS and WMS-III scores.
  • Specific cutoff scores (DRS < 37, WMS-III < 26%) demonstrated high accuracy in identifying AD converters (76.9% sensitivity, 91.7% specificity).
  • Demographic factors and vascular risk did not significantly improve predictive accuracy.

Conclusions:

  • Commonly administered neuropsychological tests can effectively identify MCI patients at risk for conversion to AD within 1-2 years.
  • These findings support the use of neuropsychological assessments for prognostic information and early treatment targeting in MCI.
  • The study highlights the potential of these methods for identifying suitable participants for Alzheimer's disease clinical trials.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.